Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 114, Issue 9, 1764-1767, August 27, 2009
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Definitive proof for direct reprogramming of hematopoietic cells to pluripotency
Blood Okabe et al. 114: 1764

Supplemental materials for: Okabe et al

Files in this Data Supplement:

  • Document 1. Supplemental materials and methods (PDF, 122 KB)

  • Table S1. Primers used for PCR analyses (PDF, 41.1 KB)

  • Figure S1. Generation of iPSCs derived from BM hematopoietic cells (JPG, 382 KB) -
    (A) Appearance of cells during the process of iPSC induction from BM HSPCs. Bar represents 100 µm. (B) SSEA-1 expression in BM hematopoietic cell-derived iPS cells (BM-derived iPSCs). Representative flow cytometric plots are shown for established BM-derived iPSCs (right) together with those for whole BM (left) and ES cells (center). Note the expression of SSEA-1 in BM-derived iPS cells at levels comparable to those in ES cells and the absence of SSEA-1 expression in whole BM cells.





  • Figure S2. Assessment of iPSC factor genes in sHSC-iPSCs (JPG, 234 KB) -
    (A) PCR analysis shows the presence of all iPSC proviruses in each sHSC-iPS clone. H2O: No-template control; Control: Positive control using each vector DNA as template. (B) RT-PCR analysis using specific primer sets to examine expression of the 4 iPSC factors. In each sHSC-iPS clone, transcripts from the endogenous genes are detectable (Endo), while those from the retroviruses are not (Tg). RT (−): No–reverse-transcriptase control; Control: Jurkat cells transduced with each retrovirus vector. Note the near-absence of Tg amplicons in test samples after 35-cycle amplification.





  • Figure S3. Assessment of expression of pluripotency markers in sHSC-iPSCs (JPG, 252 KB) -
    (A) RT-PCR analysis showing ES marker gene expression in sHSC-iPSC clones. H2O: No-template control; ES: ES cells as a positive control; RT (−): No–reverse-transcriptase control. (B) Nanog expression in sHSC-iPSC clones shown by immunostaining. NC: Negative control with isotype control antibodies. Nuclei were stained with DAPI. Bar represents 100 µm.





  • Figure S4. Developmental potential of sHSC-iPSCs (JPG, 372 KB) -
    Shown are photomicrographs of histological sections of teratomas derived from sHSC-iPSC clone #9-5. Bar represents 100 µm.





  • Figure S5. Assessment of iPSC factor genes in pHPC-iPSC (JPG, 252 KB) -
    (A) PCR analysis shows the presence of all iPSC factors in each pHPC-iPSC clone. H2O: No-template control; Control: Positive control using each vector DNA as template. (B) RT-PCR analysis using specific primer sets to examine expression of the 4 iPSC factors. In each pHPC-iPSC clone, transcripts from the endogenous genes are detectable (Endo), while those from the retroviruses are not (Tg). RT (−): No–reverse-transcriptase control; Control: Jurkat cells transduced with each retrovirus vector. Note the near-absence of Tg amplicons in test samples after 35-cycle amplification.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2010 by American Society of Hematology         Online ISSN: 1528-0020